.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
McKinsey
Harvard Business School
Accenture
UBS
Chubb
Moodys
Cipla
Boehringer Ingelheim
McKesson

Generated: November 18, 2017

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Chlorpheniramine Maleate, and when can generic versions of Hydrocodone Bitartrate And Chlorpheniramine Maleate launch?

Hydrocodone Bitartrate And Chlorpheniramine Maleate is a drug marketed by Tris Pharma Inc and Acella Pharms Llc and is included in two NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.

Summary for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; hydrocodone bitartrate
SOLUTION;ORAL206438-001Jan 27, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Acella Pharms Llc
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; hydrocodone bitartrate
SOLUTION;ORAL206891-001Jun 9, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
McKesson
Merck
Dow
Moodys
Accenture
Cerilliant
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot